Selected research
Industry Growth & Trends
Global Stem Cell Therapy for Osteoarthritis Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Stem Cell Therapy for Osteoarthritis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Stem Cell Therapy for Osteoarthritis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Stem Cell Therapy for Osteoarthritis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Stem Cell Therapy for Osteoarthritis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Stem Cell Therapy for Osteoarthritis market include Xintela AB, UCI Health, Theracell Advanced Biotechnology, Stempeutics, Regeneus, Nature Cell, Medipost, Magellan and CellTex Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Stem Cell Therapy for Osteoarthritis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Stem Cell Therapy for Osteoarthritis market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Stem Cell Therapy for Osteoarthritis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Stem Cell Therapy for Osteoarthritis.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Stem Cell Therapy for Osteoarthritis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Stem Cell Therapy for Osteoarthritis Market by Company
Xintela AB
UCI Health
Theracell Advanced Biotechnology
Stempeutics
Regeneus
Nature Cell
Medipost
Magellan
CellTex Therapeutics
Cells for Cells
AbelZeta Pharma
Stem Cell Therapy for Osteoarthritis Segment by Type
Fat Cell
Bone Marrow Cell
Others
Stem Cell Therapy for Osteoarthritis Segment by Application
Primary Osteoarthritis
Secondary Osteoarthritis
Stem Cell Therapy for Osteoarthritis Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Therapy for Osteoarthritis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Therapy for Osteoarthritis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Therapy for Osteoarthritis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Stem Cell Therapy for Osteoarthritis companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Fat Cell
- Bone Marrow Cell
- Others
Applications
- Primary Osteoarthritis
- Secondary Osteoarthritis
Companies covered
- Xintela AB
- UCI Health
- Theracell Advanced Biotechnology
- Stempeutics
- Regeneus
- Nature Cell
- Medipost
- Magellan
- CellTex Therapeutics
- Cells for Cells
- AbelZeta Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Stem Cell Therapy for Osteoarthritis Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Stem Cell Therapy for Osteoarthritis Market Size by Region (2021-2032)
- 1.4.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Region (2021-2026)
- 1.4.2 Global Stem Cell Therapy for Osteoarthritis Market Size by Region (2027-2032)
- 1.5 Key Regions Stem Cell Therapy for Osteoarthritis Market Size (2021-2032)
- 1.5.1 North America Stem Cell Therapy for Osteoarthritis Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Stem Cell Therapy for Osteoarthritis Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size Growth Rate (2021-2032)
- 1.5.4 South America Stem Cell Therapy for Osteoarthritis Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size Growth Rate (2021-2032)
2 Stem Cell Therapy for Osteoarthritis Market by Type
- 2.1 Type Introduction
- 2.1.1 Fat Cell
- 2.1.2 Bone Marrow Cell
- 2.1.3 Others
- 2.2 Global Stem Cell Therapy for Osteoarthritis Market Size by Type
- 2.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Overview by Type (2021-2032)
- 2.2.2 Global Stem Cell Therapy for Osteoarthritis Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Stem Cell Therapy for Osteoarthritis Market Size Forecasted by Type (2027-2032)
- 2.3 Global Stem Cell Therapy for Osteoarthritis Market Size by Regions
- 2.3.1 North America Stem Cell Therapy for Osteoarthritis Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Stem Cell Therapy for Osteoarthritis Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Stem Cell Therapy for Osteoarthritis Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Stem Cell Therapy for Osteoarthritis Market Size Breakdown by Type (2021-2026)
3 Stem Cell Therapy for Osteoarthritis Market by Application
- 3.1 Type Introduction
- 3.1.1 Primary Osteoarthritis
- 3.1.2 Secondary Osteoarthritis
- 3.2 Global Stem Cell Therapy for Osteoarthritis Market Size by Application
- 3.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Overview by Application (2021-2032)
- 3.2.2 Global Stem Cell Therapy for Osteoarthritis Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Stem Cell Therapy for Osteoarthritis Market Size Forecasted by Application (2027-2032)
- 3.3 Global Stem Cell Therapy for Osteoarthritis Market Size by Regions
- 3.3.1 North America Stem Cell Therapy for Osteoarthritis Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Stem Cell Therapy for Osteoarthritis Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Stem Cell Therapy for Osteoarthritis Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Stem Cell Therapy for Osteoarthritis Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Stem Cell Therapy for Osteoarthritis Industry Trends
- 4.2 Stem Cell Therapy for Osteoarthritis Industry Drivers
- 4.3 Stem Cell Therapy for Osteoarthritis Industry Opportunities and Challenges
- 4.4 Stem Cell Therapy for Osteoarthritis Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Stem Cell Therapy for Osteoarthritis Revenue (2021-2026)
- 5.2 Global Stem Cell Therapy for Osteoarthritis Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Stem Cell Therapy for Osteoarthritis Key Company Headquarters & Area Served
- 5.4 Global Stem Cell Therapy for Osteoarthritis Company, Product Type & Application
- 5.5 Global Stem Cell Therapy for Osteoarthritis Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Stem Cell Therapy for Osteoarthritis Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Stem Cell Therapy for Osteoarthritis Players Market Share by Revenue in 2025
- 5.6.3 2025 Stem Cell Therapy for Osteoarthritis Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Xintela AB
- 6.1.1 Xintela AB Company Information
- 6.1.2 Xintela AB Business Overview
- 6.1.3 Xintela AB Stem Cell Therapy for Osteoarthritis Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Xintela AB Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.1.5 Xintela AB Recent Developments
- 6.2 UCI Health
- 6.2.1 UCI Health Company Information
- 6.2.2 UCI Health Business Overview
- 6.2.3 UCI Health Stem Cell Therapy for Osteoarthritis Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 UCI Health Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.2.5 UCI Health Recent Developments
- 6.3 Theracell Advanced Biotechnology
- 6.3.1 Theracell Advanced Biotechnology Company Information
- 6.3.2 Theracell Advanced Biotechnology Business Overview
- 6.3.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.3.5 Theracell Advanced Biotechnology Recent Developments
- 6.4 Stempeutics
- 6.4.1 Stempeutics Company Information
- 6.4.2 Stempeutics Business Overview
- 6.4.3 Stempeutics Stem Cell Therapy for Osteoarthritis Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Stempeutics Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.4.5 Stempeutics Recent Developments
- 6.5 Regeneus
- 6.5.1 Regeneus Company Information
- 6.5.2 Regeneus Business Overview
- 6.5.3 Regeneus Stem Cell Therapy for Osteoarthritis Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Regeneus Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.5.5 Regeneus Recent Developments
- 6.6 Nature Cell
- 6.6.1 Nature Cell Company Information
- 6.6.2 Nature Cell Business Overview
- 6.6.3 Nature Cell Stem Cell Therapy for Osteoarthritis Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Nature Cell Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.6.5 Nature Cell Recent Developments
- 6.7 Medipost
- 6.7.1 Medipost Company Information
- 6.7.2 Medipost Business Overview
- 6.7.3 Medipost Stem Cell Therapy for Osteoarthritis Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Medipost Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.7.5 Medipost Recent Developments
- 6.8 Magellan
- 6.8.1 Magellan Company Information
- 6.8.2 Magellan Business Overview
- 6.8.3 Magellan Stem Cell Therapy for Osteoarthritis Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Magellan Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.8.5 Magellan Recent Developments
- 6.9 CellTex Therapeutics
- 6.9.1 CellTex Therapeutics Company Information
- 6.9.2 CellTex Therapeutics Business Overview
- 6.9.3 CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.9.5 CellTex Therapeutics Recent Developments
- 6.10 Cells for Cells
- 6.10.1 Cells for Cells Company Information
- 6.10.2 Cells for Cells Business Overview
- 6.10.3 Cells for Cells Stem Cell Therapy for Osteoarthritis Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Cells for Cells Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.10.5 Cells for Cells Recent Developments
- 6.11 AbelZeta Pharma
- 6.11.1 AbelZeta Pharma Company Information
- 6.11.2 AbelZeta Pharma Business Overview
- 6.11.3 AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.11.5 AbelZeta Pharma Recent Developments
7 North America
- 7.1 North America Stem Cell Therapy for Osteoarthritis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2021-2026)
- 7.3 North America Stem Cell Therapy for Osteoarthritis Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Stem Cell Therapy for Osteoarthritis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2021-2026)
- 8.3 Europe Stem Cell Therapy for Osteoarthritis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Stem Cell Therapy for Osteoarthritis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Stem Cell Therapy for Osteoarthritis Market Size by Country (2021-2026)
- 10.3 South America Stem Cell Therapy for Osteoarthritis Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst